We are live on ! Find out more
IBIO icon

iBio
IBIO

1.39 USD
-0.01
0.71%
At close Updated Aug 6, 4:00 PM EDT
Pre-market
After hours
1.40
+0.01
0.72%
1 day
-0.71%
5 days
-1.42%
1 month
-14.2%
3 months
-21.47%
6 months
-42.56%
Year to date
-31.19%
1 year
133.61%
5 years
-99.78%
10 years
-99.96%
 

About: iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Employees: 20

Healthcare Biotechnology
0
Funds holding %
of 8,143 funds
Explore Fund Trends
–
Positive news %
Check Journalist POV
Price charts implemented using Lightweight Charts™